@article{d123e49aaf53434a84a8e383bc705105,
title = "Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association",
abstract = "The objective of this study was to investigate the side effects of glucocorticoid (GC) therapy observed by European thyroidologists during the treatment of Graves' orbitopathy (GO).",
keywords = "Adult, Adverse Drug Reaction Reporting Systems, Aged, Committee Membership, Data Collection, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Drug Toxicity, Endocrinology, Europe, Female, Glucocorticoids, Graves Ophthalmopathy, Humans, Male, Methylprednisolone, Middle Aged, Physician's Practice Patterns, Questionnaires, Societies, Medical, Thyroid Gland, Young Adult",
author = "Claudio Marcocci and Torquil Watt and Altea, {Maria Antonietta} and Rasmussen, {{\AA}se Krogh} and Ulla Feldt-Rasmussen and Jacques Orgiazzi and Luigi Bartalena and {European Group of Graves' Orbitopathy}",
year = "2012",
doi = "10.1530/EJE-11-0779",
language = "English",
volume = "166",
pages = "247--53",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd",
number = "2",
}